Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.935 USD | +0.54% | -8.70% | +65.58% |
May. 14 | Durect Far From Earnings Story But FDA Commentary Shows Path Forward, Oppenheimer Says | MT |
May. 13 | Transcript : DURECT Corporation, Q1 2024 Earnings Call, May 13, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+65.58% | 28.86M | |
+9.77% | 115B | |
+11.91% | 106B | |
-2.39% | 21.96B | |
-13.81% | 21.87B | |
-5.29% | 19.21B | |
-3.39% | 18.08B | |
-38.57% | 17.71B | |
+6.27% | 14.32B | |
+34.69% | 12.42B |
- Stock Market
- Equities
- DRRX Stock
- News DURECT Corporation
- Armand P. Neukermans, Class III Director of Durect Corporation, Not to Stand for Re-Election